1. Digoxin toxicity: clinical features often non-specific

   Media release 18 March 2023 Pages: 1 - 1

2. FDA implements safeguards to prevent contaminated products in US market

   News item 18 March 2023 Pages: 2 - 2

3. Levonorgestrel IUDs: heavy menstrual bleeding and higher BMI increase risk of expulsion

   News item 18 March 2023 Pages: 3 - 3

4. Mebeverine-related headache and dizziness

   News item 18 March 2023 Pages: 4 - 4

5. Methotrexate may reduce sodium valproate levels and seizure or mood control

   News item 18 March 2023 Pages: 5 - 5

6. Metoclopramide-related dystonia in paediatric patients

   News item 18 March 2023 Pages: 6 - 6

7. Product information updates for donepezil, guanfacine and lisdexamfetamine

   News item 18 March 2023 Pages: 7 - 7

8. Semaglutide scams in Australia

   News item 18 March 2023 Pages: 8 - 8

9. Unauthorised skin lightening and mucolytic products from Kausch pose health risks

   News item 18 March 2023 Pages: 9 - 9

10. BRAF and MEK inhibitor combination therapy-related eye AEs

    Clinical study 18 March 2023 Pages: 10 - 10

11. Budesonide oral suspension well tolerated in patients with eosinophilic oesophagitis

    Clinical study 18 March 2023 Pages: 11 - 11

12. Proton pump inhibitor-related risk of rhabdomyolysis

    Clinical study 18 March 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 18 March 2023 Pages: 13 - 13

14. Abatacept/methotrexate/tocilizumab

    Case report 18 March 2023 Pages: 14 - 14

15. Acalabrutinib/ibrutinib/rituximab

    Case report 18 March 2023 Pages: 15 - 15

16. ACAM-2000

    Case report 18 March 2023 Pages: 16 - 16

17. Acitretin/methylprednisolone/thalidomide

    Case report 18 March 2023 Pages: 17 - 17

18. Ad26.cov2-s

    Case report 18 March 2023 Pages: 18 - 18

19. Ad26.cov2-s/azd-1222/tozinameran

    Case report 18 March 2023 Pages: 19 - 19

20. Ad26.cov2-s/tozinameran

    Case report 18 March 2023 Pages: 20 - 20

21. Adalimumab

    Case report 18 March 2023 Pages: 21 - 21

22. Albendazole/metronidazole/tinidazole

    Case report 18 March 2023 Pages: 22 - 22

23. Albumin-human

    Case report 18 March 2023 Pages: 23 - 23

24. Albutrepenonacog-alfa

    Case report 18 March 2023 Pages: 24 - 24

25. Alfatradiol/minoxidil/trichofoam

    Case report 18 March 2023 Pages: 25 - 25

26. Alglucosidase alfa/cetirizine/prednisolone

    Case report 18 March 2023 Pages: 26 - 26

27. Alglucosidase-alfa

    Case report 18 March 2023 Pages: 27 - 27

28. Allopurinol/cotrimoxazole/immune-globulin/prednisolone

    Case report 18 March 2023 Pages: 28 - 28

29. Alprazolam/lamotrigine/quetiapine

    Case report 18 March 2023 Pages: 29 - 29

30. Alteplase/methylprednisolone

    Case report 18 March 2023 Pages: 30 - 30

31. Amikacin/piperacillin/tazobactam

    Case report 18 March 2023 Pages: 31 - 31

32. Amiodarone

    Case report 18 March 2023 Pages: 32 - 32

33. Amiodarone

    Case report 18 March 2023 Pages: 33 - 33

34. Amiodarone/esmolol/lidocaine

    Case report 18 March 2023 Pages: 34 - 34

35. Amisulpride/armodafinil/clozapine

    Case report 18 March 2023 Pages: 35 - 35

36. Amisulpride/lorazepam/olanzapine

    Case report 18 March 2023 Pages: 36 - 36

37. Amphotericin b liposomal

    Case report 18 March 2023 Pages: 37 - 37

38. Amphotericin-b/amphotericin-b-liposomal/posaconazole

    Case report 18 March 2023 Pages: 38 - 38

39. Anastrozole

    Case report 18 March 2023 Pages: 39 - 39

40. Anastrozole/fulvestrant/letrozole

    Case report 18 March 2023 Pages: 40 - 40

41. Anastrozole/prednisone

    Case report 18 March 2023 Pages: 41 - 41

42. Antiasthematics

    Case report 18 March 2023 Pages: 42 - 42

43. Antibacterials/cardiotonics

    Case report 18 March 2023 Pages: 43 - 43

44. Antibacterials/immunosuppressants

    Case report 18 March 2023 Pages: 44 - 44

45. Antibiotics

    Case report 18 March 2023 Pages: 45 - 45

46. Anticoagulants/antiplatelets

    Case report 18 March 2023 Pages: 46 - 46

47. Antiepileptics

    Case report 18 March 2023 Pages: 47 - 47

48. Antifungals/prednisolone

    Case report 18 March 2023 Pages: 48 - 48

49. Antihistamines/omalizumab

    Case report 18 March 2023 Pages: 49 - 49

50. Antimigraines/venlafaxine

    Case report 18 March 2023 Pages: 50 - 50